LIVN
Price
$38.58
Change
-$0.48 (-1.23%)
Updated
Mar 12, 02:04 PM (EDT)
Capitalization
3.02B
49 days until earnings call
VCYT
Price
$30.98
Change
-$0.12 (-0.39%)
Updated
Mar 12, 03:31 PM (EDT)
Capitalization
1.66B
62 days until earnings call
Ad is loading...

LIVN vs VCYT

Header iconLIVN vs VCYT Comparison
Open Charts LIVN vs VCYTBanner chart's image
LivaNova
Price$38.58
Change-$0.48 (-1.23%)
Volume$300
Capitalization3.02B
Veracyte
Price$30.98
Change-$0.12 (-0.39%)
Volume$100
Capitalization1.66B
LIVN vs VCYT Comparison Chart
Loading...
LIVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LIVN vs. VCYT commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIVN is a Hold and VCYT is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (LIVN: $39.03 vs. VCYT: $31.10)
Brand notoriety: LIVN and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LIVN: 203% vs. VCYT: 132%
Market capitalization -- LIVN: $3.02B vs. VCYT: $1.66B
LIVN [@Medical Specialties] is valued at $3.02B. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIVN’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • LIVN’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than LIVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIVN’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 3 bullish TA indicator(s).

  • LIVN’s TA Score: 4 bullish, 6 bearish.
  • VCYT’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than LIVN.

Price Growth

LIVN (@Medical Specialties) experienced а -6.08% price change this week, while VCYT (@Medical Specialties) price change was -8.82% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.90%. For the same industry, the average monthly price growth was -8.26%, and the average quarterly price growth was -3.51%.

Reported Earning Dates

LIVN is expected to report earnings on Apr 30, 2025.

VCYT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (-2.90% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIVN($3.02B) has a higher market cap than VCYT($1.66B). LIVN YTD gains are higher at: -15.709 vs. VCYT (-21.465). LIVN has higher annual earnings (EBITDA): 38.5M vs. VCYT (-49.41M). LIVN has more cash in the bank: 267M vs. VCYT (216M). VCYT has less debt than LIVN: VCYT (12.6M) vs LIVN (640M). LIVN has higher revenues than VCYT: LIVN (1.15B) vs VCYT (361M).
LIVNVCYTLIVN / VCYT
Capitalization3.02B1.66B181%
EBITDA38.5M-49.41M-78%
Gain YTD-15.709-21.46573%
P/E Ratio172.28N/A-
Revenue1.15B361M320%
Total Cash267M216M124%
Total Debt640M12.6M5,079%
FUNDAMENTALS RATINGS
LIVN vs VCYT: Fundamental Ratings
LIVN
VCYT
OUTLOOK RATING
1..100
5557
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
8486
PRICE GROWTH RATING
1..100
8664
P/E GROWTH RATING
1..100
9953
SEASONALITY SCORE
1..100
38n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LIVN's Valuation (77) in the Medical Specialties industry is in the same range as VCYT (81) in the Biotechnology industry. This means that LIVN’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's Profit vs Risk Rating (88) in the Biotechnology industry is in the same range as LIVN (100) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to LIVN’s over the last 12 months.

LIVN's SMR Rating (84) in the Medical Specialties industry is in the same range as VCYT (86) in the Biotechnology industry. This means that LIVN’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's Price Growth Rating (64) in the Biotechnology industry is in the same range as LIVN (86) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to LIVN’s over the last 12 months.

VCYT's P/E Growth Rating (53) in the Biotechnology industry is somewhat better than the same rating for LIVN (99) in the Medical Specialties industry. This means that VCYT’s stock grew somewhat faster than LIVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LIVNVCYT
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
LIVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFLLX13.73N/A
N/A
Morgan Stanley Inst Inception R6
MFAPX23.98N/A
N/A
Morgan Stanley Inst Intl Advtg A
RGBHX37.22-0.11
-0.29%
American Funds Global Balanced R5E
BRXTX13.71-0.05
-0.36%
MFS Blended Research Intl Eq R3
GLNIX22.32-0.09
-0.40%
MFS Global New Discovery I

LIVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIVN has been loosely correlated with AORT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if LIVN jumps, then AORT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIVN
1D Price
Change %
LIVN100%
+5.44%
AORT - LIVN
40%
Loosely correlated
-0.09%
VCYT - LIVN
34%
Loosely correlated
+2.37%
BSX - LIVN
33%
Loosely correlated
+1.48%
AVNS - LIVN
31%
Poorly correlated
-1.01%
TMDX - LIVN
31%
Poorly correlated
+2.50%
More